Sir Peter MacCallum Department of Oncology - Research Publications

Permanent URI for this collection

Now showing 1 - 1 of 1

THE PROGNOSTIC VALUE OF IMMUNOPEROXIDASE STAINING WITH MONOCLONAL-ANTIBODIES NCRC-11 AND 3E1.2 IN BREAST-CANCER

MUIR, IM ; REED, RG ; STACKER, SA ; ALEXANDER, AI ; MCKENZIE, IFC ; BENNETT, RC (STOCKTON PRESS, 1991-07)

The variation in survival of women with clinically similar breast cancers may lead to difficulty in clinical management so it is important to recognise factors which indicate the prognosis. Immunoperoxidase staining patterns of primary breast tumours using monoclonal antibody NCRC-11 have been shown to relate to overall survival (Ellis et al., 1985) but the results have not been reproducible in other centres. In this study paraffin sections of 483 primary breast cancers were stained with NCRC-11 and 3E1.2 using an immunoperoxidase system. The tumour staining patterns were compared with overall survival using life tables and tested for relative prognostic significance by Cox's multivariate analysis. NCRC-11 related to survival in all 483 cases (chi 2 5.8, P = 0.02) but both antibodies achieved maximum prognostic significance in lymph node negative patients (chi 2 9.4, P less than 0.002 and chi 2 10.7, P less than 0.001) in whom no other factor was more significant. Immunoperoxidase staining patterns produced by monoclonal antibodies NCRC-11 and 3E1.2 are important prognostic factors in breast cancer.